Manfred Zoltobrocki

Corporate Officer/Principal en Lux Biosciences, Inc. .

Health Technology

Commercial Services

Consumer Services

Cargos activos de Manfred Zoltobrocki

Empresas	Cargo	Inicio	Fin
Lux Biosciences, Inc. Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ.	Corporate Officer/Principal	21/10/2009	-

Empresas	Cargo	Inicio	Fin
NascaCell Technologies AG NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany.	Director/Miembro de la Junta	10/06/2010	08/02/2011
Epidauros Biotechnologie AG Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million.	Presidente	-	01/03/2006
Aventis Pharma AG	Corporate Officer/Principal	01/01/2002	01/01/2002
Hoechst Marion Roussel SA	Corporate Officer/Principal	-	-
Hoechst Pharmaceuticals Ltd.	Corporate Officer/Principal	-	-

Johann Wolfgang Goethe-Universität Frankfurt am Main

Doctorate Degree

Internacional

Operativa

Corporate Officer/Principal	4
President	1
Doctorate Degree	1

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	6
Lux Biosciences, Inc. Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ.	Health Technology
Epidauros Biotechnologie AG Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million.	Commercial Services
Aventis Pharma AG
Hoechst Pharmaceuticals Ltd.
Hoechst Marion Roussel SA	Health Technology
NascaCell Technologies AG NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany.	Health Technology